Literature DB >> 2508623

Transforming growth factor beta 1 treatment of AKR-2B cells is coupled through a pertussis-toxin-sensitive G-protein(s).

P H Howe1, E B Leof.   

Abstract

Transforming growth factor beta (TGF beta 1) is a potent regulator of DNA synthesis and cellular proliferation. In this study, we investigated whether the growth stimulatory signal of TGF beta 1 is transduced intracellularly by guanine nucleotide regulatory proteins (G-proteins). In plasma membranes from AKR-2B cells, TGF beta 1 increased binding of the radiolabelled, non-hydrolysable GTP analogue, guanosine 5'-[gamma-[35S]thio]triphosphate (GTP[35S]), in a dose-dependent manner. Maximal effects occurred between 0.4 and 1.0 nM-TGF beta 1. Specific binding of GTP[35S] occurred with a Kd of 3.2 x 10(-8) M which was not affected by addition of TGF beta 1. Instead, TGF beta 1 increased the number of available binding sites for GTP[35S] from 16.2 +/- 1.2 to 21.6 +/- 2.1 pmol/mg of protein. GTP[35S] binding was both nucleotide- and growth-factor-specific. Only guanine nucleotides were able to compete for binding, and of the growth factors tested (epidermal growth factor, platelet-derived growth factor, insulin, TGF beta 1 and TGF beta 2) only TGF beta 1 affected GTP[35S] binding. TGF beta 1 increased GTPase activity, as determined by the release of 32PO4(3-) from GTP gamma[32P], from 116 +/- 5.5 to 175 +/- 4.3 pmol/mg of protein following a 15 min incubation. Pretreatment of the membranes with pertussis toxin inhibited both TGF beta 1-stimulated binding of GTP[35S] as well as TGF beta 1-stimulated GTPase activity. These inhibitory actions of pertussis toxin were associated with toxin-induced ADP-ribosylation of a 41 kDa protein. Furthermore, the stimulatory effects of TGF beta 1 on c-sis mRNA expression were shown to be pertussis-toxin sensitive and could be mimicked by direct activation of G-proteins with AIF4-. These results demonstrate that in AKR-2B cells a pertussis-toxin-sensitive guanine nucleotide regulatory protein(s) is coupled to TGF beta 1 receptor binding.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2508623      PMCID: PMC1138912          DOI: 10.1042/bj2610879

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  47 in total

Review 1.  Growth factors and cancer.

Authors:  A S Goustin; E B Leof; G D Shipley; H L Moses
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

2.  Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity.

Authors:  E B Leof; J A Proper; A S Goustin; G D Shipley; P E DiCorleto; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

3.  Thrombin stimulates c-sis gene expression in microvascular endothelial cells.

Authors:  T O Daniel; V C Gibbs; D F Milfay; M R Garovoy; L T Williams
Journal:  J Biol Chem       Date:  1986-07-25       Impact factor: 5.157

4.  Transforming growth factor type beta regulation of actin mRNA.

Authors:  E B Leof; J A Proper; M J Getz; H L Moses
Journal:  J Cell Physiol       Date:  1986-04       Impact factor: 6.384

5.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix.

Authors:  R A Ignotz; J Massagué
Journal:  J Biol Chem       Date:  1986-03-25       Impact factor: 5.157

6.  Pertussis toxin inhibits enkephalin stimulation of GTPase of NG108-15 cells.

Authors:  D L Burns; E L Hewlett; J Moss; M Vaughan
Journal:  J Biol Chem       Date:  1983-02-10       Impact factor: 5.157

7.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

8.  Effects of thrombin, phorbol myristate acetate and prostaglandin D2 on 40-41 kDa protein that is ADP ribosylated by pertussis toxin in platelets.

Authors:  S P Halenda; M Volpi; G B Zavoico; R I Sha'afi; M B Feinstein
Journal:  FEBS Lett       Date:  1986-08-18       Impact factor: 4.124

9.  Purification and properties of the inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase.

Authors:  G M Bokoch; T Katada; J K Northup; M Ui; A G Gilman
Journal:  J Biol Chem       Date:  1984-03-25       Impact factor: 5.157

10.  The subunits of the stimulatory regulatory component of adenylate cyclase. Resolution of the activated 45,000-dalton (alpha) subunit.

Authors:  J K Northup; M D Smigel; P C Sternweis; A G Gilman
Journal:  J Biol Chem       Date:  1983-09-25       Impact factor: 5.157

View more
  9 in total

1.  Transforming growth factor beta as a potential tumor progression factor among hyperdiploid glioblastoma cultures: evidence for the role of platelet-derived growth factor.

Authors:  M T Jennings; C E Hart; P A Commers; J A Whitlock; D Martincic; R J Maciunas; P L Moots; T M Shehab
Journal:  J Neurooncol       Date:  1997-02       Impact factor: 4.130

2.  Transforming Growth Factor-β1 Decreases β2-Agonist-induced Relaxation in Human Airway Smooth Muscle.

Authors:  Christie A Ojiaku; Elena Chung; Vishal Parikh; Jazmean K Williams; Anthony Schwab; Ana Lucia Fuentes; Maia L Corpuz; Victoria Lui; Sam Paek; Natalia M Bexiga; Shreya Narayan; Francisco J Nunez; Kwangmi Ahn; Rennolds S Ostrom; Steven S An; Reynold A Panettieri
Journal:  Am J Respir Cell Mol Biol       Date:  2019-08       Impact factor: 6.914

3.  Inhibition of mink lung epithelial cell proliferation by transforming growth factor-beta is coupled through a pertussis-toxin-sensitive substrate.

Authors:  P H Howe; M R Cunningham; E B Leof
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

Review 4.  The role of transforming growth factor beta in glioma progression.

Authors:  M T Jennings; J A Pietenpol
Journal:  J Neurooncol       Date:  1998-01       Impact factor: 4.130

5.  Opposite and independent actions of cyclic AMP and transforming growth factor beta in the regulation of type 1 plasminogen activator inhibitor expression.

Authors:  F W Thalacker; M Nilsen-Hamilton
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

6.  Transforming growth factor beta decreases the rate of proliferation of rat vascular smooth muscle cells by extending the G2 phase of the cell cycle and delays the rise in cyclic AMP before entry into M phase.

Authors:  D J Grainger; P R Kemp; C M Witchell; P L Weissberg; J C Metcalfe
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

7.  Regulation of fibroblast procollagen production. Transforming growth factor-beta 1 induces prostaglandin E2 but not procollagen synthesis via a pertussis toxin-sensitive G-protein.

Authors:  R J McAnulty; R C Chambers; G J Laurent
Journal:  Biochem J       Date:  1995-04-01       Impact factor: 3.857

8.  Investigation of guanine-nucleotide-binding protein involvement and regulation of cyclic AMP metabolism in interleukin 1 signal transduction.

Authors:  K Ray; N Thompson; N Kennard; P Rollins; S Grenfell; S Witham; N Smithers; R Solari
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

9.  Transforming growth factor beta 1 inhibition of p34cdc2 phosphorylation and histone H1 kinase activity is associated with G1/S-phase growth arrest.

Authors:  P H Howe; G Draetta; E B Leof
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.